Severe hepatitis in three AIDS patients treated with indinavir [6]

Lancet

Volumn 349, Issue 9056, 1997, Pages 924-925

  Bräu, Norbert ^b   Leaf, Howard L ^b   Wieczorek, Rosemary L ^b   Margolis, David M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; DOXEPIN; DRONABINOL; ERYTHROPOIETIN; FLUCONAZOLE; INDINAVIR; LAMIVUDINE; METHADONE; NORTRIPTYLINE; RANITIDINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RIFABUTIN; ZIDOVUDINE;

ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE HEPATITIS; ADULT; CASE REPORT; COMBINATION CHEMOTHERAPY; FEMALE; HUMAN; JAUNDICE; LETTER; MALE; PRIORITY JOURNAL;

EID: 0342618506     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62700-6     Document Type: Article

References (2)

1. Gulick RM, Mellors J, Havlir D, et al. Potent and sustained antiretroviral activity of indinavir, zidovudine and lamivudine. Presented at XI International Conference on AIDS, Vancouver, 1996 (abstr ThB931).
2. Indinavir prescribing information, Merck & Co Inc, West Point, PA 19486, USA.